Neurotech Solutions

Company Overview

Snapshot

Founded in March 2008, Neurotech Solutions operates with 11–50 employees. The company has secured $3.55M in total capital across three funding rounds from three investors. In March 2018, Neurotech Solutions received funding from Guangzhou Sino-Israel Biotech Investment Fund (GIBF) to fuel its aggressive growth in the ADHD screening and diagnosis market in China.

Business overview

Neurotech Solutions is a digital health company dedicated to addressing undiagnosed ADHD. The company's core offering is a cloud-based, AI-driven online test, designed to resemble a game, which serves as a decision-support tool for ADHD diagnosis. This technology is implemented in its clinical product, MOXO d-CPT, used by healthcare professionals for objective, standardized assessments, and in its educational product, AXON-School, which identifies attentional difficulties in K-12 children and suggests personalized learning strategies. Neurotech Solutions operates within the Health Tech & Life Sciences sector, specifically in Digital Healthcare and Medical Decision Support, serving healthcare providers, educational institutions, and consumers globally.

Strategic signal

In March 2018, Neurotech Solutions secured significant funding from Guangzhou Sino-Israel Biotech Investment Fund (GIBF) to accelerate its expansion in the Chinese market for ADHD screening and diagnosis. This strategic investment highlights the growing international recognition of Neurotech's AI-driven diagnostic tools and signals a strong focus on global market penetration, particularly in key Asian markets, validating the company's technology and business model for international growth.

Company Intelligence Q&A

What is Neurotech Solutions' primary focus?

Neurotech Solutions is a digital health company focused on eliminating undiagnosed ADHD and helping individuals with ADHD improve their lives and fulfill their potential.

What is the core technology behind Neurotech Solutions' products?

The company's core technology is a cloud-based, AI-driven online test that functions like a game, providing objective and standardized results for attentional difficulties.

Which clinical product utilizes Neurotech Solutions' technology?

Neurotech Solutions' technology is implemented in MOXO d-CPT, a clinical product that serves as a decision-support tool for the diagnosis of ADHD.

What is the purpose of AXON-School?

AXON-School is an educational product from Neurotech Solutions intended for K-12 children, designed to objectively highlight attentional difficulties and suggest educational strategies for personalized learning.

When did Neurotech Solutions expand into China?

Neurotech Solutions opened a subsidiary in Guangzhou, China, in 2021, and in March 2018, the company secured funding to support the growth of its ADHD screening and diagnosis business in China.